Options
Günther, René
Loading...
Preferred name
Günther, René
Official Name
Günther, René
Alternative Name
Günther, R.
Günther, Rene
Main Affiliation
Now showing 1 - 8 of 8
2019Journal Article [["dc.bibliographiccitation.firstpage","175628641984605"],["dc.bibliographiccitation.journal","Therapeutic Advances in Neurological Disorders"],["dc.bibliographiccitation.volume","12"],["dc.contributor.author","Wurster, Claudia D."],["dc.contributor.author","Günther, René"],["dc.contributor.author","Steinacker, Petra"],["dc.contributor.author","Dreyhaupt, Jens"],["dc.contributor.author","Wollinsky, Kurt"],["dc.contributor.author","Uzelac, Zeljko"],["dc.contributor.author","Witzel, Simon"],["dc.contributor.author","Kocak, Tugrul"],["dc.contributor.author","Winter, Benedikt"],["dc.contributor.author","Koch, Jan C."],["dc.contributor.author","Lingor, Paul"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Ludolph, Albert C."],["dc.contributor.author","Hermann, Andreas"],["dc.contributor.author","Otto, Markus"],["dc.date.accessioned","2020-12-10T18:38:37Z"],["dc.date.available","2020-12-10T18:38:37Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1177/1756286419846058"],["dc.identifier.eissn","1756-2864"],["dc.identifier.issn","1756-2864"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16746"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77390"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.notes.intern","Merged from goescholar"],["dc.rights","CC BY-NC 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by-nc/4.0"],["dc.title","Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI2019Journal Article [["dc.bibliographiccitation.firstpage","36"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Neurology"],["dc.bibliographiccitation.lastpage","44"],["dc.bibliographiccitation.volume","267"],["dc.contributor.author","Wurster, Claudia D."],["dc.contributor.author","Steinacker, Petra"],["dc.contributor.author","Günther, René"],["dc.contributor.author","Koch, Jan C."],["dc.contributor.author","Lingor, Paul"],["dc.contributor.author","Uzelac, Zeljko"],["dc.contributor.author","Witzel, Simon"],["dc.contributor.author","Wollinsky, Kurt"],["dc.contributor.author","Winter, Benedikt"],["dc.contributor.author","Osmanovic, Alma"],["dc.contributor.author","Schreiber-Katz, Olivia"],["dc.contributor.author","Al Shweiki, Rami"],["dc.contributor.author","Ludolph, Albert C."],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Hermann, Andreas"],["dc.contributor.author","Otto, Markus"],["dc.date.accessioned","2020-12-10T14:10:34Z"],["dc.date.available","2020-12-10T14:10:34Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1007/s00415-019-09547-y"],["dc.identifier.eissn","1432-1459"],["dc.identifier.issn","0340-5354"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70801"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2022Journal Article [["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.journal","Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],["dc.bibliographiccitation.lastpage","10"],["dc.contributor.author","Meyer, Thomas"],["dc.contributor.author","Spittel, Susanne"],["dc.contributor.author","Grehl, Torsten"],["dc.contributor.author","Weyen, Ute"],["dc.contributor.author","Steinbach, Robert"],["dc.contributor.author","Kettemann, Dagmar"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Weydt, Patrick"],["dc.contributor.author","Günther, René"],["dc.contributor.author","Baum, Petra"],["dc.contributor.author","Maier, André"],["dc.date.accessioned","2022-09-01T09:50:25Z"],["dc.date.available","2022-09-01T09:50:25Z"],["dc.date.issued","2022"],["dc.description.sponsorship","Boris Canessa ALS Stiftung"],["dc.description.sponsorship","Bremer ALS Stiftung"],["dc.description.sponsorship","BMBF"],["dc.identifier.doi","10.1080/21678421.2022.2104649"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/113709"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-597"],["dc.relation.eissn","2167-9223"],["dc.relation.issn","2167-8421"],["dc.rights.uri","http://creativecommons.org/licenses/by-nc-nd/4.0/"],["dc.title","Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2021Journal Article [["dc.bibliographiccitation.firstpage","372"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Brain Sciences"],["dc.bibliographiccitation.volume","11"],["dc.contributor.affiliation","Peseschkian, Tara; \t\t \r\n\t\t Department of Neurology, Hannover Medical School, 30625 Hannover, Germany, Peseschkian.Tara@mh-hannover.de"],["dc.contributor.affiliation","Cordts, Isabell; \t\t \r\n\t\t Department of Neurology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany, isabell.cordts@tum.de"],["dc.contributor.affiliation","Günther, René; \t\t \r\n\t\t Department of Neurology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany, Rene.Guenther@uniklinikum-dresden.de\t\t \r\n\t\t German Center for Neurodegenerative Diseases (DZNE), 01307 Dresden, Germany, Rene.Guenther@uniklinikum-dresden.de"],["dc.contributor.affiliation","Stolte, Benjamin; \t\t \r\n\t\t Department of Neurology, University Medicine Essen, 45147 Essen, Germany, benjamin.stolte@uk-essen.de"],["dc.contributor.affiliation","Zeller, Daniel; \t\t \r\n\t\t Department of Neurology, University of Würzburg, 97080 Würzburg, Germany, Zeller_D@ukw.de"],["dc.contributor.affiliation","Schröter, Carsten; \t\t \r\n\t\t Hoher Meißner Clinic, Neurology, 37242 Bad Sooden-Allendorf, Germany, Schroeter@reha-klinik.de"],["dc.contributor.affiliation","Weyen, Ute; \t\t \r\n\t\t Department of Neurology, Ruhr-University Bochum, BG-Kliniken Bergmannsheil, 44789 Bochum, Germany, ute.weyen@bergmannsheil.de"],["dc.contributor.affiliation","Regensburger, Martin; \t\t \r\n\t\t Department of Molecular Neurology, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany, Martin.Regensburger@uk-erlangen.de"],["dc.contributor.affiliation","Wolf, Joachim; \t\t \r\n\t\t Department of Neurology, Diakonissen Hospital Mannheim, 68163 Mannheim, Germany, j.wolf@diako-mannheim.de"],["dc.contributor.affiliation","Schneider, Ilka; \t\t \r\n\t\t Department of Neurology, Martin-Luther University Halle/Saale, 06120 Halle, Germany, Ilka.Schneider@sanktgeorg.de\t\t \r\n\t\t Department of Neurology, Klinikum Sankt Georg, 04129 Leipzig, Germany, Ilka.Schneider@sanktgeorg.de"],["dc.contributor.affiliation","Hermann, Andreas; \t\t \r\n\t\t Translational Neurodegeneration Section “Albrecht-Kossel”, Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany, Andreas.Hermann@med.uni-rostock.de\t\t \r\n\t\t German Center for Neurodegenerative Diseases Rostock/Greifswald, 18147 Rostock, Germany, Andreas.Hermann@med.uni-rostock.de"],["dc.contributor.affiliation","Metelmann, Moritz; \t\t \r\n\t\t Department of Neurology, University Hospital Leipzig, 04103 Leipzig, Germany, Moritz.Metelmann@medizin.uni-leipzig.de"],["dc.contributor.affiliation","Kohl, Zacharias; \t\t \r\n\t\t Department of Neurology, University of Regensburg, 93053 Regensburg, Germany, zacharias.kohl@klinik.uni-regensburg.de"],["dc.contributor.affiliation","Linker, Ralf A.; \t\t \r\n\t\t Department of Neurology, University of Regensburg, 93053 Regensburg, Germany, Ralf.Linker@klinik.uni-regensburg.de"],["dc.contributor.affiliation","Koch, Jan Christoph; \t\t \r\n\t\t Department of Neurology, University Medicine Göttingen, 37075 Göttingen, Germany, jkoch@med.uni-goettingen.de"],["dc.contributor.affiliation","Büchner, Boriana; \t\t \r\n\t\t Friedrich-Baur Institute, Department of Neurology, University Hospital, Ludwig Maximilian University of Munich, 80336 Munich, Germany, Boriana.Buechner@med.uni-muenchen.de"],["dc.contributor.affiliation","Weiland, Ulrike; \t\t \r\n\t\t Department of Neurology, University of Ulm, 89081 Ulm, Germany, Ulrike.Weiland@uniklinik-ulm.de"],["dc.contributor.affiliation","Schönfelder, Erik; \t\t \r\n\t\t Department of Neurology, Hannover Medical School, 30625 Hannover, Germany, Erik.Schoenfelder@stud.mh-hannover.de"],["dc.contributor.affiliation","Heinrich, Felix; \t\t \r\n\t\t Department of Neurology, Hannover Medical School, 30625 Hannover, Germany, Felix.Heinrich@stud.mh-hannover.de"],["dc.contributor.affiliation","Osmanovic, Alma; \t\t \r\n\t\t Department of Neurology, Hannover Medical School, 30625 Hannover, Germany, dr.almaosmanovic@gmail.com"],["dc.contributor.affiliation","Klopstock, Thomas; \t\t \r\n\t\t Friedrich-Baur Institute, Department of Neurology, University Hospital, Ludwig Maximilian University of Munich, 80336 Munich, Germany, Thomas.Klopstock@med.uni-muenchen.de\t\t \r\n\t\t Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany, Thomas.Klopstock@med.uni-muenchen.de\t\t \r\n\t\t German Center for Neurodegenerative Diseases (DZNE), 80336 Munich, Germany, Thomas.Klopstock@med.uni-muenchen.de"],["dc.contributor.affiliation","Dorst, Johannes; \t\t \r\n\t\t Department of Neurology, University of Ulm, 89081 Ulm, Germany, johannes.dorst@rku.de"],["dc.contributor.affiliation","Ludolph, Albert C.; \t\t \r\n\t\t Department of Neurology, University of Ulm, 89081 Ulm, Germany, albert.ludolph@rku.de\t\t \r\n\t\t German Center for Neurodegenerative Diseases (DZNE), 89081 Ulm, Germany, albert.ludolph@rku.de"],["dc.contributor.affiliation","Boentert, Matthias; \t\t \r\n\t\t Department of Neurology with the Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany, Matthias.Boentert@ukmuenster.de\t\t \r\n\t\t Department of Medicine, UKM Marienhospital, 48565 Steinfurt, Germany, Matthias.Boentert@ukmuenster.de"],["dc.contributor.affiliation","Hagenacker, Tim; \t\t \r\n\t\t Department of Neurology, University Medicine Essen, 45147 Essen, Germany, tim.hagenacker@uk-essen.de"],["dc.contributor.affiliation","Deschauer, Marcus; \t\t \r\n\t\t Department of Neurology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany, marcus.deschauer@mri.tum.de"],["dc.contributor.affiliation","Lingor, Paul; \t\t \r\n\t\t Department of Neurology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany, paul.lingor@tum.de"],["dc.contributor.affiliation","Petri, Susanne; \t\t \r\n\t\t Department of Neurology, Hannover Medical School, 30625 Hannover, Germany, Petri.Susanne@mh-hannover.de"],["dc.contributor.affiliation","Schreiber-Katz, Olivia; \t\t \r\n\t\t Department of Neurology, Hannover Medical School, 30625 Hannover, Germany, Schreiber-Katz.Olivia@mh-hannover.de"],["dc.contributor.author","Peseschkian, Tara"],["dc.contributor.author","Cordts, Isabell"],["dc.contributor.author","Günther, René"],["dc.contributor.author","Stolte, Benjamin"],["dc.contributor.author","Zeller, Daniel"],["dc.contributor.author","Schröter, Carsten"],["dc.contributor.author","Weyen, Ute"],["dc.contributor.author","Regensburger, Martin"],["dc.contributor.author","Wolf, Joachim"],["dc.contributor.author","Schneider, Ilka"],["dc.contributor.author","Hermann, Andreas"],["dc.contributor.author","Metelmann, Moritz"],["dc.contributor.author","Kohl, Zacharias"],["dc.contributor.author","Linker, Ralf A."],["dc.contributor.author","Koch, Jan Christoph"],["dc.contributor.author","Büchner, Boriana"],["dc.contributor.author","Weiland, Ulrike"],["dc.contributor.author","Schönfelder, Erik"],["dc.contributor.author","Heinrich, Felix"],["dc.contributor.author","Osmanovic, Alma"],["dc.contributor.author","Klopstock, Thomas"],["dc.contributor.author","Dorst, Johannes"],["dc.contributor.author","Ludolph, Albert C."],["dc.contributor.author","Boentert, Matthias"],["dc.contributor.author","Hagenacker, Tim"],["dc.contributor.author","Deschauer, Marcus"],["dc.contributor.author","Lingor, Paul"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Schreiber-Katz, Olivia"],["dc.date.accessioned","2021-04-14T08:27:57Z"],["dc.date.available","2021-04-14T08:27:57Z"],["dc.date.issued","2021"],["dc.date.updated","2022-02-09T13:21:17Z"],["dc.description.sponsorship","German Neuromuscular Society “Deutsche Gesellschaft fuer Muskelkranke\" e.V."],["dc.identifier.doi","10.3390/brainsci11030372"],["dc.identifier.eissn","2076-3425"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/82457"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.publisher","MDPI"],["dc.relation.eissn","2076-3425"],["dc.rights","https://creativecommons.org/licenses/by/4.0/"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0/"],["dc.title","A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2022Journal Article [["dc.bibliographiccitation.artnumber","acn3.51645"],["dc.bibliographiccitation.journal","Annals of Clinical and Translational Neurology"],["dc.contributor.author","Freigang, Maren"],["dc.contributor.author","Steinacker, Petra"],["dc.contributor.author","Wurster, Claudia D."],["dc.contributor.author","Schreiber‐Katz, Olivia"],["dc.contributor.author","Osmanovic, Alma"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Koch, Jan C."],["dc.contributor.author","Rostásy, Kevin"],["dc.contributor.author","Huss, André"],["dc.contributor.author","Tumani, Hayrettin"],["dc.contributor.author","Günther, René"],["dc.date.accessioned","2022-09-01T09:51:18Z"],["dc.date.available","2022-09-01T09:51:18Z"],["dc.date.issued","2022"],["dc.identifier.doi","10.1002/acn3.51645"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/113929"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-597"],["dc.relation.eissn","2328-9503"],["dc.relation.issn","2328-9503"],["dc.title","Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2022Journal Article [["dc.bibliographiccitation.journal","JAMA Neurology"],["dc.contributor.author","Witzel, Simon"],["dc.contributor.author","Maier, André"],["dc.contributor.author","Steinbach, Robert"],["dc.contributor.author","Grosskreutz, Julian"],["dc.contributor.author","Koch, Jan C."],["dc.contributor.author","Sarikidi, Anastasia"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Günther, René"],["dc.contributor.author","Wolf, Joachim"],["dc.contributor.author","Hermann, Andreas"],["dc.contributor.author","Ludolph, Albert C."],["dc.contributor.authorgroup","German Motor Neuron Disease Network (MND-NET)"],["dc.date.accessioned","2022-02-01T10:31:06Z"],["dc.date.available","2022-02-01T10:31:06Z"],["dc.date.issued","2022"],["dc.identifier.doi","10.1001/jamaneurol.2021.4893"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/98785"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-517"],["dc.relation.issn","2168-6149"],["dc.title","Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2021Journal Article [["dc.bibliographiccitation.artnumber","330"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Orphanet Journal of Rare Diseases"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Freigang, Maren"],["dc.contributor.author","Steinacker, Petra"],["dc.contributor.author","Wurster, Claudia Diana"],["dc.contributor.author","Schreiber-Katz, Olivia"],["dc.contributor.author","Osmanovic, Alma"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Koch, Jan Christoph"],["dc.contributor.author","Rostásy, Kevin"],["dc.contributor.author","Falkenburger, Björn"],["dc.contributor.author","Ludolph, Albert Christian"],["dc.contributor.author","Günther, René"],["dc.date.accessioned","2021-09-01T06:38:26Z"],["dc.date.available","2021-09-01T06:38:26Z"],["dc.date.issued","2021"],["dc.description.abstract","Abstract Background Studies regarding the impact of (neuro)inflammation and inflammatory response following repetitive, intrathecally administered antisense oligonucleotides (ASO) in 5q-associated spinal muscular atrophy (SMA) are sparse. Increased risk of hydrocephalus in untreated SMA patients and a marginal but significant increase of the serum/CSF albumin ratio (Qalb) with rare cases of communicating hydrocephalus during nusinersen treatment were reported, which confirms the unmet need of an inflammatory biomarker in SMA. The aim of this study was to investigate the (neuro)inflammatory marker chitotriosidase 1 (CHIT1) in SMA patients before and following the treatment with the ASO nusinersen. Methods In this prospective, multicenter observational study, we studied CSF CHIT1 concentrations in 58 adult and 21 pediatric patients with SMA type 1, 2 or 3 before treatment initiation in comparison to age- and sex-matched controls and investigated its dynamics during nusinersen treatment. Concurrently, motor performance and disease severity were assessed. Results CHIT1 concentrations were elevated in treatment-naïve SMA patients as compared to controls, but less pronounced than described for other neurodegenerative diseases such as amyotrophic lateral sclerosis. CHIT1 concentration did not correlate with disease severity and did not distinguish between clinical subtypes. CHIT1 concentration did show a significant increase during nusinersen treatment that was unrelated to the clinical response to nusinersen therapy. Conclusions CHIT1 elevation in treatment-naïve SMA patients indicates the involvement of (neuro)inflammation in SMA. The lacking correlation of CHIT1 concentration with disease severity argues against its use as a marker of disease progression. The observed CHIT1 increase during nusinersen treatment may indicate an immune response-like, off-target reaction. Since antisense oligonucleotides are an establishing approach in the treatment of neurodegenerative diseases, this observation needs to be further evaluated."],["dc.description.abstract","Abstract Background Studies regarding the impact of (neuro)inflammation and inflammatory response following repetitive, intrathecally administered antisense oligonucleotides (ASO) in 5q-associated spinal muscular atrophy (SMA) are sparse. Increased risk of hydrocephalus in untreated SMA patients and a marginal but significant increase of the serum/CSF albumin ratio (Qalb) with rare cases of communicating hydrocephalus during nusinersen treatment were reported, which confirms the unmet need of an inflammatory biomarker in SMA. The aim of this study was to investigate the (neuro)inflammatory marker chitotriosidase 1 (CHIT1) in SMA patients before and following the treatment with the ASO nusinersen. Methods In this prospective, multicenter observational study, we studied CSF CHIT1 concentrations in 58 adult and 21 pediatric patients with SMA type 1, 2 or 3 before treatment initiation in comparison to age- and sex-matched controls and investigated its dynamics during nusinersen treatment. Concurrently, motor performance and disease severity were assessed. Results CHIT1 concentrations were elevated in treatment-naïve SMA patients as compared to controls, but less pronounced than described for other neurodegenerative diseases such as amyotrophic lateral sclerosis. CHIT1 concentration did not correlate with disease severity and did not distinguish between clinical subtypes. CHIT1 concentration did show a significant increase during nusinersen treatment that was unrelated to the clinical response to nusinersen therapy. Conclusions CHIT1 elevation in treatment-naïve SMA patients indicates the involvement of (neuro)inflammation in SMA. The lacking correlation of CHIT1 concentration with disease severity argues against its use as a marker of disease progression. The observed CHIT1 increase during nusinersen treatment may indicate an immune response-like, off-target reaction. Since antisense oligonucleotides are an establishing approach in the treatment of neurodegenerative diseases, this observation needs to be further evaluated."],["dc.identifier.doi","10.1186/s13023-021-01961-8"],["dc.identifier.pii","1961"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88933"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-455"],["dc.relation.eissn","1750-1172"],["dc.title","Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI2021Journal Article [["dc.bibliographiccitation.firstpage","1049"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Annals of Clinical and Translational Neurology"],["dc.bibliographiccitation.lastpage","1063"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Freigang, Maren"],["dc.contributor.author","Wurster, Claudia D."],["dc.contributor.author","Hagenacker, Tim"],["dc.contributor.author","Stolte, Benjamin"],["dc.contributor.author","Weiler, Markus"],["dc.contributor.author","Kamm, Christoph"],["dc.contributor.author","Schreiber‐Katz, Olivia"],["dc.contributor.author","Osmanovic, Alma"],["dc.contributor.author","Petri, Susanne"],["dc.contributor.author","Günther, René"],["dc.date.accessioned","2021-06-01T09:41:44Z"],["dc.date.available","2021-06-01T09:41:44Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1002/acn3.51340"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/85020"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.relation.eissn","2328-9503"],["dc.relation.issn","2328-9503"],["dc.title","Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI